11/20
07:06 am
acxp
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset [Yahoo! Finance]
High
Report
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset [Yahoo! Finance]
11/20
07:01 am
acxp
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
High
Report
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
11/20
07:01 am
acxp
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
High
Report
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
11/20
07:01 am
acxp
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
High
Report
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
11/18
07:12 am
acxp
Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update [Yahoo! Finance]
Low
Report
Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update [Yahoo! Finance]
11/18
07:00 am
acxp
Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update
Low
Report
Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update
11/14
08:15 am
acxp
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
11/14
02:21 am
acxp
Acurx Pharmaceuticals Inc (ACXP) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Medium
Report
Acurx Pharmaceuticals Inc (ACXP) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
11/13
07:00 am
acxp
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update
Medium
Report
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update
10/26
06:14 pm
acxp
AccreditedEvents.com Unveils Premier Lineup for November and December Investor Events [Yahoo! Finance]
Low
Report
AccreditedEvents.com Unveils Premier Lineup for November and December Investor Events [Yahoo! Finance]
10/21
10:10 am
acxp
Acurx Ready To Expand Pipeline With Anthrax Treatment [Seeking Alpha]
Low
Report
Acurx Ready To Expand Pipeline With Anthrax Treatment [Seeking Alpha]
10/21
07:00 am
acxp
Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference
Low
Report
Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference
10/17
08:00 am
acxp
Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement
Low
Report
Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement
10/16
08:00 am
acxp
Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024
Low
Report
Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024
10/14
01:00 pm
acxp
New to the Street Resigns Acurx Pharmaceuticals, Inc. to Multi-Platform Media Series Featuring Broadcast Television, Earned Media, and Outdoor Advertising Support
Low
Report
New to the Street Resigns Acurx Pharmaceuticals, Inc. to Multi-Platform Media Series Featuring Broadcast Television, Earned Media, and Outdoor Advertising Support
10/11
11:13 am
acxp
New to the Street Announces Exclusive Bloomberg Lineup for Saturday October 12 at 6:30 PM EST [Yahoo! Finance]
Neutral
Report
New to the Street Announces Exclusive Bloomberg Lineup for Saturday October 12 at 6:30 PM EST [Yahoo! Finance]
10/11
10:45 am
acxp
New to the Street Announces Exclusive Bloomberg Lineup for October 11 at 6:30 PM EST
Low
Report
New to the Street Announces Exclusive Bloomberg Lineup for October 11 at 6:30 PM EST
9/26
07:00 am
acxp
Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues
Medium
Report
Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues
9/24
07:00 am
acxp
Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium
High
Report
Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium
9/9
08:30 am
acxp
New to the Street Announces Its Five Corporate Interviews, Airing Episode 599 on the Fox Business Network, Tonight Monday, September 9, 2024, at 10:30 PM PT September 9, 2024 09:15 ET
Low
Report
New to the Street Announces Its Five Corporate Interviews, Airing Episode 599 on the Fox Business Network, Tonight Monday, September 9, 2024, at 10:30 PM PT September 9, 2024 09:15 ET
8/26
09:15 am
acxp
New to The Street Announces its Five Corporate Interviews, Airing Episode 591 on the Fox Business Network, Tonight Monday, August 26, 2024, at 10:30 PM PT
Low
Report
New to The Street Announces its Five Corporate Interviews, Airing Episode 591 on the Fox Business Network, Tonight Monday, August 26, 2024, at 10:30 PM PT
8/26
07:00 am
acxp
ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment Conference
8/25
11:07 am
acxp
We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate [Yahoo! Finance]
Medium
Report
We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate [Yahoo! Finance]